Literature DB >> 17034924

A 90-day dietary study on kappa carrageenan with emphasis on the gastrointestinal tract.

Myra L Weiner1, David Nuber, William R Blakemore, Jay F Harriman, Samuel M Cohen.   

Abstract

Groups of Fischer 344 rats (20/sex/group) received control or treated diets at levels of 0, 25,000 or 50,000 ppm kappa carrageenan with a molecular weight range (Mw) of 196,000-257,000 Da for 90 days. The Low Molecular Weight Tail (LMT) ranged between 1.9% and 12.0%<50 kDa (mean 7%) based on the results of a program initiated to develop a validated analytical method to measure the LMT. This is the first GLP dietary study in which carrageenan is characterized by percentage LMT. Clinical examinations were performed daily. Individual food consumption/body weight measurements were made weekly. Ophthalmic exam was conducted prior to and at the end of treatment. Hematology/serum chemistry and urinalysis evaluations were done at necropsy, as were organ weight determinations for adrenals, brain, heart, kidneys, liver, ovaries, spleen, testes and thyroid with parathyroids. Full histopathological evaluation of organs was conducted on the control and 50,000 ppm groups, including hematoxylin-eosin-stained cross sections of paraffin-embedded rolled colon. Clinical signs were limited to soft feces in high dose rats and to a lesser extent in low dose rats. There were no treatment-related effects on body weights, urinalysis, hematology or clinical chemistry parameters, or on organ weights or ophthalmic, macroscopic or microscopic findings. The gastrointestinal tract appeared normal in detailed histopathological evaluation using the Swiss roll technique. The NOAEL is 50,000 ppm in the diet (mean calculated test material consumption of 3394+/-706 mg/kg/day in males, 3867+/-647 mg/kg/day in females). The results of the study provide evidence that it is not necessary to characterize carrageenan by a specification for LMT (less than 5% below 50 kDa) as has been done in Commission Directive 2004/45/EC of 16 April 2004 (Commission Directive, 2004/45/EC of 16 April 2004 amending Directive 96/77/EC laying down specific purity criteria on food additives other than colors and sweeteners. Official Journal of European Union 20 April, 2004, L113/19-L113/21).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034924     DOI: 10.1016/j.fct.2006.07.033

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  10 in total

1.  Components of the cultivated red seaweed Chondrus crispus enhance the immune response of Caenorhabditis elegans to Pseudomonas aeruginosa through the pmk-1, daf-2/daf-16, and skn-1 pathways.

Authors:  Jinghua Liu; Jeff Hafting; Alan T Critchley; Arjun H Banskota; Balakrishnan Prithiviraj
Journal:  Appl Environ Microbiol       Date:  2013-09-20       Impact factor: 4.792

2.  Comparative in silico-in vivo evaluation of ASGP-R ligands for hepatic targeting of curcumin Gantrez nanoparticles.

Authors:  Anisha A D'Souza; Puneet Jain; C N Galdhar; Abdul Samad; Mariam S Degani; Padma V Devarajan
Journal:  AAPS J       Date:  2013-04-12       Impact factor: 4.009

3.  Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice.

Authors:  Guangchun Jin; Vigneshwaran Ramanathan; Michael Quante; Gwang Ho Baik; Xiangdong Yang; Sophie S W Wang; Shuiping Tu; Shanisha A K Gordon; David Mark Pritchard; Andrea Varro; Arthur Shulkes; Timothy C Wang
Journal:  J Clin Invest       Date:  2009-08-03       Impact factor: 14.808

4.  Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects.

Authors:  Sergey N Fedorov; Svetlana P Ermakova; Tatyana N Zvyagintseva; Valentin A Stonik
Journal:  Mar Drugs       Date:  2013-12-02       Impact factor: 5.118

Review 5.  Algae as nutritional and functional food sources: revisiting our understanding.

Authors:  Mark L Wells; Philippe Potin; James S Craigie; John A Raven; Sabeeha S Merchant; Katherine E Helliwell; Alison G Smith; Mary Ellen Camire; Susan H Brawley
Journal:  J Appl Phycol       Date:  2016-11-21       Impact factor: 3.215

6.  Effect of Carrageenans on Vegetable Jelly in Humans with Hypercholesterolemia.

Authors:  Ana Valado; Maria Pereira; Armando Caseiro; João P Figueiredo; Helena Loureiro; Carla Almeida; João Cotas; Leonel Pereira
Journal:  Mar Drugs       Date:  2019-12-24       Impact factor: 5.118

7.  Experimental Evaluation of Food-Grade Semi-Refined Carrageenan Toxicity.

Authors:  Denys Pogozhykh; Yevgen Posokhov; Valeriy Myasoedov; Galina Gubina-Vakulyck; Tetyana Chumachenko; Oleksandr Knigavko; Hanna Polikarpova; Yuliia Kalashnyk-Vakulenko; Ketino Sharashydze; Oksana Nakonechna; Volodymyr Prokopyuk; Anatolii Onishchenko; Anton Tkachenko
Journal:  Int J Mol Sci       Date:  2021-10-16       Impact factor: 5.923

8.  Degraded carrageenan causing colitis in rats induces TNF secretion and ICAM-1 upregulation in monocytes through NF-kappaB activation.

Authors:  Claudine Benard; Antonietta Cultrone; Catherine Michel; Carlos Rosales; Jean-Pierre Segain; Marc Lahaye; Jean-Paul Galmiche; Christine Cherbut; Hervé M Blottière
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

9.  Mast cells and pro-inflammatory cytokines roles in assessment of grape seeds extract anti-inflammatory activity in rat model of carrageenan-induced paw edema.

Authors:  Amany Ahmed Mohamed Abd-Allah; Nasr Abdelwahab Mohamed Nasr El-Deen; Wafaa Abdou Mohamed Mohamed; Fatma Mohamed Naguib
Journal:  Iran J Basic Med Sci       Date:  2018-01       Impact factor: 2.699

10.  The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis.

Authors:  Guangchun Jin; Kosuke Sakitani; Hongshan Wang; Ying Jin; Alexander Dubeykovskiy; Daniel L Worthley; Yagnesh Tailor; Timothy C Wang
Journal:  Oncotarget       Date:  2017-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.